These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15990182

  • 1. Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay.
    Janecka A, Poels J, Fichna J, Studzian K, Vanden Broeck J.
    Regul Pept; 2005 Nov; 131(1-3):23-8. PubMed ID: 15990182
    [Abstract] [Full Text] [Related]

  • 2. Recombinant aequorin as a reporter for receptor-mediated changes of intracellular Ca2+ -levels in Drosophila S2 cells.
    Torfs H, Poels J, Detheux M, Dupriez V, Van Loy T, Vercammen L, Vassart G, Parmentier M, Vanden Broeck J.
    Invert Neurosci; 2002 Apr; 4(3):119-24. PubMed ID: 12488971
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T, Shirahase H, Kanda M, Kunishiro K, Kurahashi K.
    Vascul Pharmacol; 2009 Apr; 51(2-3):147-53. PubMed ID: 19539781
    [Abstract] [Full Text] [Related]

  • 6. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
    Lecci A, Capriati A, Altamura M, Maggi CA.
    Auton Neurosci; 2006 Jun 30; 126-127():232-49. PubMed ID: 16616700
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of neurokinins on canine prostate cell physiology.
    Walden PD, Marinese D, Srinivasan D, Tzoumaka E, Syyong HT, Ford AP, Bhattacharya A.
    Prostate; 2005 Jun 01; 63(4):358-68. PubMed ID: 15611996
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
    Rigby M, O'Donnell R, Rupniak NM.
    J Comp Neurol; 2005 Oct 03; 490(4):335-53. PubMed ID: 16127708
    [Abstract] [Full Text] [Related]

  • 12. Tachykinin receptor expression and function in human esophageal smooth muscle.
    Kovac JR, Chrones T, Preiksaitis HG, Sims SM.
    J Pharmacol Exp Ther; 2006 Aug 03; 318(2):513-20. PubMed ID: 16714401
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological assessment of spantide II analogues.
    Wang ZY, Feng DM, Wang YL, Tung SR, Wong K, Strichartz GR, Folkers K, Håkanson R.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):121-8. PubMed ID: 7527343
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological evidence for neurokinin receptors in murine neuroblastoma C1300 cells.
    Fukuhara S, Mukai H, Munekata E.
    Peptides; 1995 Aug 01; 16(2):211-4. PubMed ID: 7540290
    [Abstract] [Full Text] [Related]

  • 15. A role for tachykinins in female mouse and rat reproductive function.
    Pintado CO, Pinto FM, Pennefather JN, Hidalgo A, Baamonde A, Sanchez T, Candenas ML.
    Biol Reprod; 2003 Sep 01; 69(3):940-6. PubMed ID: 12773411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X, Proietto V, Steinberg R, Oury-Donat F, Vigé X, Vilain P, Naline E, Daoui S, Advenier C, Le Fur G, Maffrand JP, Soubrié P, Pascal M.
    J Pharmacol Exp Ther; 2002 Dec 01; 303(3):1171-9. PubMed ID: 12438541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A.
    Lavagno L, Bordin G, Colangelo D, Viano I, Brunelleschi S.
    Neuropeptides; 2001 Apr 01; 35(2):92-9. PubMed ID: 11384204
    [Abstract] [Full Text] [Related]

  • 20. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
    Salthun-Lassalle B, Traver S, Hirsch EC, Michel PP.
    Mol Pharmacol; 2005 Nov 01; 68(5):1214-24. PubMed ID: 16077032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.